<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>CTD_GIM</author_name>
  <author_url>https://blog.hatena.ne.jp/CTD_GIM/</author_url>
  <blog_title>膠原病・リウマチ一人抄読会</blog_title>
  <blog_url>https://ctd-gim.hatenablog.com/</blog_url>
  <categories>
    <anon>その他</anon>
  </categories>
  <description>American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1 [published online ahead of print, 2021 Mar 17]. Arthritis Rheumatol. 2021;10.1002/art.41734. （https://onlinelibrary.wiley.com/doi/10.1002/art.41734） 9人のリウマチ専門医/免疫学者・…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2021%2F03%2F19%2F202038&quot; title=&quot;リウマチ性疾患患者に対してのCOVID-19ワクチンACRガイドライン- Ver.1 - 膠原病・リウマチ一人抄読会&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url></image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2021-03-19 20:20:38</published>
  <title>リウマチ性疾患患者に対してのCOVID-19ワクチンACRガイドライン- Ver.1</title>
  <type>rich</type>
  <url>https://ctd-gim.hatenablog.com/entry/2021/03/19/202038</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
